Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Custom Health HoldingsTSX:CHLT +0.69%8 Debt-to-EBITDA is -0.30 as of Jun. 2026. GuruFocus rates TSX:CHLT with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 479 Healthcare Providers & Services companies, Custom Health Holdings ranks worse than 208768.06% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Custom Health Holdings's Debt-to-EBITDA or its related term are showing as below:
TSX:CHLT'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.22 Med: 30.24 Max: 30.24
Current: -1.22
During the past 1 years, the highest Debt-to-EBITDA Ratio of Custom Health Holdings was 30.24. The lowest was -1.22. And the median was 30.24.
TSX:CHLT's Debt-to-EBITDA is ranked worse than 100% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 2.19
vs TSX:CHLT: -1.22
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Custom Health Holdings Debt-to-EBITDA Related Terms
Custom Health Holdings Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Custom Health Holdings's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Custom Health Holdings Debt-to-EBITDA Chart
Custom Health Holdings Annual Data
Trend
Mar25
Debt-to-EBITDA
30.24
Custom Health Holdings Quarterly Data
Mar25
Mar26
Jun26
Debt-to-EBITDA
N/A
N/A
-0.30
TSX:CHLT vs VEEV, BTSG, TEM: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, Custom Health Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Custom Health Holdings Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Custom Health Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Custom Health Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Custom Health Holdings (TSX:CHLT) has a Debt-to-EBITDA of -0.30 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Custom Health Holdings. According to the industry distribution chart, Custom Health Holdings ranks #999999 out of 479 companies in the Healthcare Providers & Services industry.
Is Custom Health Holdings' Debt-to-EBITDA too high?
Custom Health Holdings' current Debt-to-EBITDA is -0.30. Based on the distribution chart, Custom Health Holdings ranks #999999 out of 479 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Custom Health Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Custom Health Holdings' Debt-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Custom Health Holdings ranks #999999 out of 479 companies for Debt-to-EBITDA. This places Custom Health Holdings in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Custom Health Holdings. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Custom Health Holdings's current Debt-to-EBITDA is -0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Custom Health Holdings stock overvalued right now?
Custom Health Holdings (TSX:CHLT) has a current Debt-to-EBITDA of -0.30. The current Debt-to-EBITDA is -0.30. Custom Health Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Custom Health Holdings (TSX:CHLT), the current Debt-to-EBITDA is -0.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Custom Health Holdings Inc connects pharmacy, in-home technology, and pharmacist-led clinical oversight to create earlier visibility into how medications are used and experienced at home. Its solutions are Provider, Health Plans & Government, and Patients & Caregivers.
8GF Score
Get the complete analysis for TSX:CHLT
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:CHLT has been successfully added to your 
